|
CBX4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.238200E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.819680E-02 |
| Normal-vs-Stage2 |
5.242000E-02 |
| Normal-vs-Stage3 |
6.460000E-02 |
| Normal-vs-Stage4 |
7.269800E-02 |
| Stage1-vs-Stage2 |
3.523600E-01 |
| Stage1-vs-Stage3 |
6.916100E-02 |
| Stage1-vs-Stage4 |
7.098100E-02 |
| Stage2-vs-Stage3 |
7.053000E-01 |
| Stage2-vs-Stage4 |
6.156600E-01 |
| Stage3-vs-Stage4 |
8.852000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.258100E-02 |
| Normal-vs-AfricanAmerican |
2.698000E-01 |
| Normal-vs-Asian |
8.111600E-01 |
| Caucasian-vs-AfricanAmerican |
1.219360E-03 |
| Caucasian-vs-Asian |
3.510200E-01 |
| AfricanAmerican-vs-Asian |
7.897200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.502500E-02 |
| Normal-vs-Female |
5.486500E-02 |
| Male-vs-Female |
1.690360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.044600E-03 |
| Normal-vs-Age(41-60Yrs) |
3.108200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.205500E-02 |
| Normal-vs-Age(81-100Yrs) |
8.912200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.543400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.209750E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.965800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.846800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.451200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.838800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.179400E-01 |
| Normal-vs-Grade 2 |
2.258400E-02 |
| Normal-vs-Grade 3 |
2.194400E-02 |
| Normal-vs-Grade 4 |
2.129600E-01 |
| Grade 1-vs-Grade 2 |
1.379360E-01 |
| Grade 1-vs-Grade 3 |
1.352180E-01 |
| Grade 1-vs-Grade 4 |
4.959400E-01 |
| Grade 2-vs-Grade 3 |
9.520600E-01 |
| Grade 2-vs-Grade 4 |
2.139500E-03 |
| Grade 3-vs-Grade 4 |
4.960600E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.578600E-03 |
| Normal-vs-ccB subtype |
3.536200E-02 |
| ccA subtype-vs-ccB subtype |
3.043900E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.622420E-02 |
| Normal-vs-N1 |
4.169200E-01 |
| N0-vs-N1 |
1.075160E-01 |
|
|
